# Hair Growth Capsules Show Promise for Stress-Related Thinning in Eight-Week Trial
A new formulation of hair growth capsules targets the hormonal and stress-related factors behind hair loss, with early results suggesting measurable improvements in hair density and thickness.
The product underwent an eight-week trial period, with before and after photography documenting changes in hair growth patterns. The formulation addresses two primary drivers of hair thinning: elevated cortisol levels from chronic stress and hormonal imbalances that disrupt the hair growth cycle.
Hair loss linked to stress and hormones operates through distinct biological pathways. When cortisol remains elevated, it prematurely pushes hair follicles from the growth phase into the shedding phase, a condition called telogen effluvium. Hormonal fluctuations, particularly involving androgens and thyroid function, can shrink hair follicles over time, producing thinner strands.
The capsules combine ingredients designed to address both mechanisms. Adaptogens help regulate cortisol response, while botanical compounds support hormonal balance. The eight-week timeline aligns with the hair growth cycle, allowing researchers to observe whether follicles return to active growth phases.
Before and after photography from the trial shows visible improvements in hair density at the scalp. Participants reported subjective assessments of reduced shedding and improved hair texture, though individual results varied.
The approach reflects growing recognition that hair thinning requires targeted intervention rather than one-size-fits-all solutions. Stress-related hair loss differs from male or female pattern baldness in its reversibility, provided the underlying triggers receive proper attention.
While the eight-week trial provides encouraging visual documentation, longer-term studies would clarify whether benefits persist beyond this period and establish optimal dosing protocols. Hair regrowth typically requires sustained treatment, as follicles need